Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Telmisartan + Amlodipine
- Therapeutic area
- Cardiovascular
- Drug class
- Calcium-channel blockers
- ATC
- C08CA
- Strength
- 5 mg + 40 mg
- Dosage form
- Tablet
- Pack
- 14's
- Registration no.
- 102804
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Scilife Pharma Private Limited
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Telysa-AM (Telmisartan with amlodipine) is used for
This is a prescription tablet that contains two blood pressure medicines. Telmisartan is an angiotensin II receptor blocker (ARB): it blocks a natural substance that makes blood vessels narrow. Amlodipine is a calcium channel blocker: it relaxes and widens blood vessels. Working in two different ways, they let the blood vessels relax so blood flows more easily and blood pressure goes down.
- High blood pressure (hypertension), on its own or with other blood pressure medicines
- As a first treatment for people whose blood pressure is likely to need more than one medicine to control
- Lowering blood pressure helps reduce the risk of heart attacks and strokes
Get medical help straight away if
- Call an ambulance or go to the emergency department for swelling of the face, lips, tongue or throat, trouble breathing or swallowing, or a raised itchy rash. This can be a severe allergic reaction or angioedema, which can be life-threatening.
- Get emergency help for chest pain, especially soon after starting the medicine or after the strength is raised, as angina or a heart attack can rarely happen.
- Get urgent help if you faint.
- Contact a doctor straight away for sudden, severe tummy pain that does not go away, or tummy pain with feeling sick, vomiting and diarrhoea. This can be pancreatitis or swelling of the gut.
Side effects, warnings and interactions for Telmisartan with amlodipine
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Telmisartan + Amlodipine
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Telmisartan + Amlodipine is right for you and the dose.
- High blood pressure (hypertension): used when one medicine is not enough
About Telysa-AM 5 mg + 40 mg tablet
Telysa-AM 5 mg + 40 mg tablet contains Telmisartan + Amlodipine 5 mg + 40 mg. It is registered with DRAP by Scilife Pharma Private Limited (registration no. 102804). Its official price is PKR 553.98 for a pack of 14's, about PKR 39.57 per tablet. This price has applied since 27 July 2026. It is sold in 2 pack sizes: 14's and 30's. Telysa-AM is also available as 10 mg + 40 mg tablet, 10 mg + 80 mg tablet, 40 mg + 10 mg tablet and 40 mg + 5 mg tablet. 8 other brands of Telmisartan + Amlodipine 5 mg + 40 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Telysa-AM 5 mg + 40 mg pack sizes and prices
| Pack | Official price | Per tablet |
|---|---|---|
| 14's (this page) | PKR 553.98 | PKR 39.57 |
| 30's | PKR 1,000.17 | PKR 33.34 |
Other strengths of Telysa-AM
All 8 other brands of Telmisartan + Amlodipine 5 mg + 40 mg tablet in Pakistan
These 8 brands are alternatives (substitutes) to Telysa-AM: each contains Telmisartan + Amlodipine 5 mg + 40 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is Ezitab-AM 5 (Werrick Pharmaceuticals) at PKR 45.51 per tablet; the highest is AM-TELSAN 5 at PKR 56.17. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Ezitab-AM 5 | Werrick Pharmaceuticals | 14's | PKR 637.07 | PKR 45.51 / tablet |
| CRESAR AM | TABROS PHARMA (PVT). LTD | 14's | PKR 669.75 | PKR 47.84 / tablet |
| Sofvasc-Telm | Wilson's Pharmaceuticals | 14's | PKR 683.83 | PKR 48.85 / tablet |
| TALAM | CCL Pharmaceuticals (Pvt.) Limited | 14's | PKR 683.83 | PKR 48.85 / tablet |
| Telpine | Remington Pharmaceutical Industries (Pvt) Ltd | 2x7's | PKR 710.63 | PKR 50.76 / tablet |
| Telnip-A | The Searle Company Limited | 14's | PKR 735.79 | PKR 52.56 / tablet |
| Telmis-A | M/s. Genix Pharma (Pvt) Ltd | 14's | PKR 735.79 | PKR 52.56 / tablet |
| AM-TELSAN 5 | Hilton Pharma (Pvt) Limited | 14's | PKR 786.40 | PKR 56.17 / tablet |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Telysa-AM, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Scilife Pharma Private Limited, Karachi
- DRAP registration
- 102804
- Phone
- +92 21 111 724 543
- career@scilife.biz
- Website
- https://scilife.biz/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (14's). Current price PKR 553.98, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Telysa-AM 5 mg + 40 mg, 14's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/telysa-am-5-mg-40-mg-102804-14s-scilife-pharma-private-limited-7822/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 553.98 | 2026-07-27 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Cite this record
Medicine record · DRAP registration 102804Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.